Recent IONS News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 01:34:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2024 10:30:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2024 10:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2024 10:30:42 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 11/13/2024 01:55:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 09:17:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 09:16:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 09:15:20 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 03:52:38 PM
- Ionis to present at upcoming investor conferences • PR Newswire (US) • 11/07/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2024 09:06:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 04:15:52 PM
- Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome • PR Newswire (US) • 11/06/2024 12:01:00 PM
- Ionis reports third quarter 2024 financial results • PR Newswire (US) • 11/06/2024 12:00:00 PM
- Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE • PR Newswire (US) • 11/04/2024 02:44:00 PM
- Ionis to hold third quarter 2024 financial results webcast • PR Newswire (US) • 10/23/2024 11:05:00 AM
- WAINZUA (eplontersen) recommended for approval in the EU by CHMP for the treatment of adults with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis • PR Newswire (US) • 10/21/2024 06:08:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 10:42:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 10:39:29 PM
- New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting • PR Newswire (US) • 10/03/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 10:01:54 PM
- Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease • PR Newswire (US) • 10/01/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/10/2024 09:19:04 PM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM